Axsome Therapeutics, Inc. (AXSM)
168.11
-0.40
(-0.23%)
USD |
NASDAQ |
Apr 06, 14:31
Axsome Therapeutics SG&A Expense (TTM) : 570.60M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| Amicus Therapeutics, Inc. | 383.49M |
| Insmed, Inc. | 701.17M |
| MannKind Corp. | 229.86M |